RM
+
White blood cell attacking Streptococcus pneumoniae bacteria SEM
RM
+
White blood cell interacting with Klebsiella pneumoniae bacteria TEM
RM
+
White blood cell interacting with Klebsiella pneumoniae bacterium SEM
RM
+
White blood cell interacting with Klebsiella pneumoniae bacterium SEM
RM
+
White blood cell interacting with Klebsiella pneumoniae bacteria SEM
RF
+
Nanobodies and Covid-19 virus spike protein illustration
RM
+
HIV-1 glycoprotein GP120 and antibody illustration
RM
+
Echovirus3 capsid complexed with 6D10 Fab illustration
RM
+
Echovirus3 capsid complexed with 6D10 Fab illustration
ED
+
White smoke billows from the chloride distillation plant (left) and employees work to neutralize it (430 pm on April 12)
RM
+
Anti-HIV-1 antibody PCDN-16B molecular model The image shows the light (pink) and heavy chain (green) PCDN-16B a broadly neutralizing antibody a
RM
+
Anti-HIV-1 antibody PCDN-16B molecular model The image shows the light (pink) and heavy chain (green) PCDN-16B a broadly neutralizing antibody a
RM
+
Molecular model of VRC01 antibody by NIAIDNATIONAL INSTITUTES OF HEALTHSCIENCE PHOTO LIBRARY
RM
+
SARS-CoV-2 spike glycoprotein complexed with neutralizing antibody XG005 The image shows the spike glycoprotein (red green blue) and the antibody l
RM
+
SARS-CoV-2 spike glycoprotein complexed with neutralizing antibody XG005 The image shows the spike glycoprotein (red green blue) and the antibody l
RM
+
Anthrax toxin prepore complex
RM
+
Anthrax toxin prepore complex
RM
+
Pistol self-cleaving ribozyme class molecular model The pistol ribozyme is an RNA structure that catalyses its own cleavage at a specific site Self
RM
+
Pistol self-cleaving ribozyme class molecular model The pistol ribozyme is an RNA structure that catalyses its own cleavage at a specific site Self
ED
+
CINEMA Manifesto of the film Murderers Row (Matt Helm not forgive) Based on the homonymous novel published in 1962 by the Swedish-American wr
RF
+
Antibodies binding influenza virus Illustration of human antibodies (orange) neutralizing a influenza virus particle (blue) Each Y-shaped molecule h
RF
+
Antibodies binding influenza virus illustration
RM
+
Molecular model of SARS-CoV-2 spike complexed with a neutralizing synthetic nanobody mNb6 The image shows the trimeric spike structure (blue red ye
RM
+
SARS-CoV-2 spike complexed with nanobody molecular model
RF
+
Molecular model of nanobodies (blue) binding to the receptor binding domain (RBD) of the SARS-CoV-2 coronavirus spike (S) protein (red) S proteins ar
RF
+
Molecular model of nanobodies (blue) binding to the receptor binding domain (RBD) of the SARS-CoV-2 coronavirus spike (S) protein (red) S proteins ar
RM
+
Virus and antibodies Computer artwork of a virus particle (purple) surrounded by antibodies (Y-shaped) Antibodies are assemblies of proteins that al
RM
+
Viruses and antibodies artwork
RM
+
Pupil performing titration Schoolgirl dripping measured volumes of an acid from a burette (down right) The conical flask (lower right) contains a me
ED
+
Immunoglobulin G antibody Molecular model of the antibody immunoglobulin G (IgG) This Y-shaped protein is produced by B-lymphocyte white blood cells
RM
+
Pupil performing titration Schoolgirl dripping measured volumes of an acid from a burette (down centre) The conical flask (bottom centre) contains a
RM
+
Students performing a titration
RM
+
Student performing titration
RM
+
MERS (Middle East respiratory syndrome) coronavirus spike with neutralizing antibody CDC2-C2 Computer model showing the virus spike protein (cyan) co
RM
+
Structural 3D visualization of the spike protein 5utf from HIV-1 This lateral surface view of the structure was visualized with UCSF ChimeraX softwar
RM
+
Structural 3D visualization of the spike protein 5utf from HIV-1 This lateral ribbon view of the structure was visualized with UCSF ChimeraX software
RF
+
Illustration of the antigen binding fragment (Fab) of a cross-reactive neutralising antibody (centre) that targets the CD4 binding site of the HIV-1 (
RF
+
Illustration of the antigen binding fragment (Fab) of a cross-reactive neutralising antibody (centre) that targets the CD4 binding site of the HIV-1 (
RF
+
Illustration of the antigen binding fragment (Fab) of a cross-reactive neutralising antibody (centre) that targets the CD4 binding site of the HIV-1 (
ED
+
Pupil performing titration Schoolgirl dripping measured volumes of an acid from a burette (down centre) The conical flask (lower centre) contains
RF
+
Illustration of the antigen binding fragment (Fab) of a cross-reactive neutralising antibody (centre) that targets the CD4 binding site of the HIV-1 (
RF
+
Cross-reactive HIV antibody fragment illustration
RF
+
Illustration of the antigen binding fragment (Fab) of a cross-reactive neutralising antibody (centre) that targets the CD4 binding site of the HIV-1 (
RF
+
Cross-reactive HIV antibody fragment illustration
RM
+
Human anti-Hepatitis antibody Computer model showing the structure of the complex formed by the human anti-Hepatitis C glycoprotein E2 Fab fragment H
RM
+
Human anti-Hepatitis antibody Computer model showing the structure of the complex formed by the human anti-Hepatitis C glycoprotein E2 Fab fragment H
RM
+
HIV-1 (human immunodeficiency virus-1) GP120 and GP41 complexed with antibodies Computer model showing the structure of the complex of the trimer GP1
RM
+
HIV-1 (human immunodeficiency virus-1) GP120 and GP41 complexed with antibodies Computer model showing the structure of the complex of the trimers GP
RM
+
Crystal Structure of anti-SARS m396 antibody Molecular model of the structure of severe acute respiratory syndrome (SARS) coronavirus receptor-bindin
ED
+
Titration experiment to measure the volume of acid needed to neutralize an alkaline solution The alkaline solution is in the conical flask (bottom ce
RM
+
Crystal structure of a cross-Reactive HIV-1 neutralizing CD4-binding site antibody Fab m18 Molecular model of the crystal structure of a cross-reacti
RM
+
Anti-SARS m396 antibody
RM
+
Neutralizing human IgG1 B12 against HiV-1
RM
+
Crystal structure of a cross-Reactive HIV-1 neutralizing CD4-binding site antibody Fab m18 Molecular model of the crystal structure of a cross-reacti
RM
+
Crystal structure of a neutralizing human IgG1 B12 against HIV-1 Molecular model of the crystal structure of a neutralizing human IgG1 B12 against HI
RM
+
Anti-HIV-1 Antibody in Complex with a peptide mimotope Molecular model of an antibody that acts to neutralize the human immunodeficiency virus (HIV)
RM
+
Anti-HIV-1 Antibody in Complex with a peptide mimotope Molecular model of an antibody that acts to neutralize the human immunodeficiency virus (HIV)
RM
+
HIV-neutralizing antibody Molecular model of an antibody that acts to neutralize the human immunodeficiency virus (HIV) This antibody acts against H
RM
+
HIV-neutralizing antibody Molecular model of an antibody that acts to neutralize the human immunodeficiency virus (HIV) This antibody acts against H
ED
+
Antibody Molecular graphic of the electron density surface of the antibody immunoglobulin G (IgG) This Y-shaped protein is produced by B- lymphocyte
RM
+
Haemagglutinin viral surface protein Molecular model of haemagglutinin a surface protein from the influenza virus complexed with a neutralising ant
RM
+
Haemagglutinin viral surface protein Molecular model of haemagglutinin a surface protein from the influenza virus complexed with a neutralising ant
RM
+
Haemagglutinin protein subunit Molecular model of the ectodomain of the haemagglutinin HA(2) subunit Haemagglutinin is a surface protein from the in
RM
+
Haemagglutinin protein subunit Molecular model of the ectodomain of the haemagglutinin HA(2) subunit Haemagglutinin is a surface protein from the in
RM
+
Molecular model of nanobodies (yellow) binding to the receptor binding domain (RBD pink) of the SARS-CoV-2 coronavirus spike (S) protein (blue) S pr
RM
+
Molecular model of nanobodies (yellow) binding to the receptor binding domain (RBD pink) of the SARS-CoV-2 coronavirus spike (S) proteins (blue) S p
RM
+
Molecular model of nanobodies (yellow) binding to the receptor binding domain (RBD pink) of the SARS-CoV-2 coronavirus spike (S) protein (blue) S pr
RM
+
Molecular model of nanobodies (yellow) binding to the receptor binding domain (RBD pink) of the SARS-CoV-2 coronavirus spike (S) protein (blue) S pr
RM
+
Molecular model of nanobodies (yellow) binding to the receptor binding domain (RBD pink) of the SARS-CoV-2 coronavirus spike (S) protein (blue) S pr
ED
+
Indigestion tablets Indigestion tablets effervescing as they dissolve in a glass of water These antacids neutralize stomach acids reducing pain and
RM
+
SARS-CoV-2 spike protein complex illustration SARS-CoV-2 spike protein (cyan) complexed with neutralizing antibody CB6 Light fab chain shown in pin
RM
+
SARS-CoV-2 spike protein complex illustration SARS-CoV-2 spike protein (cyan) complexed with neutralizing antibody CB6 Light fab chain shown in pin
RM
+
SARS-CoV-2 spike glycoprotein complex illustration SARS-CoV-2 spike glycoprotein trimer (red blue yellow) complexed with neutralizing antibody EY6
RM
+
SARS-CoV-2 spike glycoprotein complex illustration SARS-CoV-2 spike glycoprotein trimer (red blue yellow) complexed with neutralizing antibody EY6
RM
+
Haemagglutinin viral surface protein Molecular model of haemagglutinin a surface protein from the influenza virus complexed with a neutralising ant
RM
+
Haemagglutinin viral surface protein Molecular model of haemagglutinin a surface protein from the influenza virus complexed with a neutralising ant
RM
+
Haemagglutinin viral surface protein Molecular model of haemagglutinin a surface protein from the influenza virus complexed with a neutralising ant
RM
+
Haemagglutinin viral surface protein Molecular model of haemagglutinin a surface protein from the influenza virus complexed with a neutralising ant
RM
+
HIV antibody and glycoprotein complex Molecular model of the anti-human immunodeficiency virus type 1 (anti-HIV-1) antibody 2F5 in complex with the g
ED
+
Antibody Molecular graphic of the electron density surface of the antibody immunoglobulin G (IgG) This Y-shaped protein is produced by B- lymphocyte
RM
+
HIV antibody and glycoprotein complex Molecular model of the anti-human immunodeficiency virus type 1 (anti-HIV-1) antibody 2F5 in complex with the g
RM
+
Skin damage immune response Computer artwork showing the bodys immune response to pathogens (red dots) entering through a skin wound (upper centre)
RM
+
Molecular model of antibodies (blue) attached to the N-terminal domain of the SARS-CoV-2 coronavirus spike (S) protein (yellow) S proteins are found
RM
+
Molecular model of antibodies (blue) attached to the N-terminal domain of the SARS-CoV-2 coronavirus spike (S) protein (yellow) S proteins are found
RM
+
Molecular model of antibodies (blue) attached to the N-terminal domain of the SARS-CoV-2 coronavirus spike (S) protein (yellow) S proteins are found
RM
+
Molecular model of antibodies (blue) attached to the N-terminal domain of the SARS-CoV-2 coronavirus spike (S) protein (yellow) S proteins are found
RM
+
Molecular model of antibodies (blue) attached to the N-terminal domain of the SARS-CoV-2 coronavirus spike (S) protein (yellow) S proteins are found
RM
+
Sodium bicarbonate Polarised light micrograph of crystals of sodium bicarbonate (sodium hydrogen carbonate) It has the chemical formula NaHCO3 Sod
RF
+
H5N1 haemagglutinin protein subunit Molecular model of the haemagglutinin HA(5) subunit Haemagglutinin is a surface protein from the influenza A vir
ED
+
Antibody Molecular graphic of the electron density surface of the antibody immunoglobulin G (IgG) This Y-shaped protein is produced by B- lymphocyte
RF
+
Haemagglutinin protein subunit Molecular model of the ectodomain of the haemagglutinin HA(2) subunit Haemagglutinin is a surface protein from the in
RF
+
Haemagglutinin viral surface protein Molecular model of haemagglutinin a surface protein from the influenza virus complexed with a neutralising ant
RF
+
Haemagglutinin viral surface protein Molecular model of haemagglutinin a surface protein from the influenza virus complexed with a neutralising ant
RF
+
Haemagglutinin viral surface protein Molecular model of haemagglutinin a surface protein from the influenza virus complexed with a neutralising ant
RF
+
H5N1 haemagglutinin protein subunit Molecular model of the haemagglutinin HA(5) subunit Haemagglutinin is a surface protein from the influenza A vir
RF
+
Haemagglutinin protein subunit Molecular model of the ectodomain of the haemagglutinin HA(2) subunit Haemagglutinin is a surface protein from the in
RF
+
Haemagglutinin viral surface protein Molecular model of haemagglutinin a surface protein from the influenza virus complexed with a neutralising ant
RM
+
Multidomain antibody MD3606 molecular model Illustration of camelid single-domain antibodies (yellow) and influenza virus hemagglutinin fusion prote
RM
+
virus
ED
+
Diphtheria toxin Molecular graphic of the diphtheria toxin in closed (left) and open form This lethal toxin is secreted by the bacteria Corynebacter
116
0
https://www.afloimages.com/search/neutralizing.html